MENU
IONS
AS OF
Nov 19, 04:59 PM (EDT)
Price
$74.04
Change
-$0.46 (-0.62%)
Capitalization
11.99B
97 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
IONS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ionis Pharmaceuticals (IONS) Ownership - Who owns Ionis Pharmaceuticals?

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
2855 Gazelle Court
Phone
+1 760 931-9200
Employees
927
Web
https://www.ionispharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
11.99B
P/E Ratio
N/A
Total Cash
2.24B
Projected Growth
N/A
Total Debt
1.49B
Revenue
966.96M
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash/Share
13.83
Total Debt/Equity
N/A
Revenue/Share
6.09 USD as % of share price

Fundamentals

IONS
Capitalization
12B
P/E Ratio
N/A
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash
2.24B
Total Cash/Share
13.83
Total Debt
1.49B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.09%
Revenue
967M
ROE
N/A
Book Value
618M
P/B Ratio
19.38
Cash Flow
N/A
Earnings
-1.61
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
161K
Current Ratio
2.79
Current Revenue Per Employee
487647.25
Dividends Per Share - Security
N/A
EBITDA
-153.61M
Float
N/A
Float - Current
N/A
Gross Income Margin
98.51
Revenue To Assets
-8.39
Shares Held By Institutions
17.1B
Shares Outstanding - Current
162M
Total Liabilities
2.42B
Total Volume MTD
N/A
Value
-1
Gain YTD
111.670
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IONS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IONS showed earnings on October 29, 2025. You can read more about the earnings report here.
View AI-Driven Trading for IONS
A.I. Advisor
published General Information

General Information

a developer of antisense drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2855 Gazelle Court
Phone
+1 760 931-9200
Employees
927
Web
https://www.ionispharma.com